Custom Clinical Trial Supply Kits

What Is Clinical Trial Supply Packaging?

Clinical trial supply packaging is the outer carton, insert tray, and printed materials used to package investigational medicinal products for patient dispensing. It is designed with space for protocol-specific labelling, lot number, expiry, protocol code, and patient identifier, and is often blinded, meaning no active ingredient branding appears on the outer carton.

What Is a Custom Clinical Trial Supply Kit?

A custom clinical trial supply kit coordinates the outer carton or rigid box, an insert tray holding the IMP and any accessories, and printed materials such as patient diaries and dosing cards. The carton is designed with variable data fields left blank for lot, expiry, and patient ID printing during fill and finish. It is used by pharmaceutical sponsors, contract research organisations, clinical packaging CMOs, and study teams that need the packed product and protocol copy considered together. Easy Box Packaging produces the secondary packaging only; filling, release, and regulatory sign-off remain with the responsible clinical partner.

Who Uses Clinical Trial Supply Kits?

This format is for teams preparing patient kits, investigational medicinal product cartons, blinded supplies, or multi-period study packs. The brief should identify the primary package, bottle, blister, ampoule, vial, pouch, or combination, plus the patient-facing instructions and accessories. A kit may be dispensed at a site, sent to a participant, or held for a defined study period. That route determines whether a folding carton, fitted tray, wallet, rigid box, or multi-compartment structure is appropriate.

What Labelling Does a Clinical Trial Kit Need?

The protocol and regulatory team should review a structured labelling checklist before the dieline is confirmed:

• Variable data fields: Reserve blank areas for lot number, expiry date, protocol code, site code, and patient identifier printing during fill and finish.
• Blinding: Keep active ingredient branding off the outer carton when the protocol requires blinded packaging; use the approved study identifier instead.
• Protocol copy: Provide the current protocol-specific label text, study number, storage instruction, and dispensing language before artwork is placed.
• Patient materials: Confirm whether a patient diary, dosing card, return instruction, or investigator sheet needs a dedicated insert position.
• Tamper evidence: Identify whether a perforated seal, shrink band, or breakaway label is required by the sponsor or packager.
• Regional requirements: Confirm ICH E6 and local labelling requirements for each country or study route with the clinical regulatory team.
• Production responsibility: Mark which variable printing and final pack operations are performed by the clinical packager or CMO.

The clinical regulatory team remains responsible for approving the protocol copy. Easy Box Packaging can coordinate the printed surfaces, insert relationship, and blank variable-field areas, but a packaging quote is not a GMP or regulatory determination. Share the approved label text before the dieline is drawn so the structure can be reviewed against the actual study brief.

Which Clinical Trial Kit Structure Fits the Brief?

The table compares common structure directions at the first briefing stage. The frequent mistake is choosing a carton from the primary container alone; blinding, variable fields, patient materials, tamper evidence, and dispensing route should set the structure.

| Structure | Best for | Blinding suitability | Variable data field space | Tamper-evident option |
| --- | --- | --- | --- | --- |
| Folding carton | Standard IMP carton for one bottle, blister, or pouch | High when the outer face carries only approved study identifiers | Broad printed faces; reserve blank fields before artwork | Perforated seal or breakaway label where supported |
| Rigid box + insert | Multi-dose patient kit or protective presentation | High when the lid and base use protocol-specific copy | Tray and outer faces require coordinated field planning | Seal or shrink band can be reviewed with the packager |
| Multi-compartment rigid | Multi-period or multi-arm supply with accessories | High when each compartment is coded without active branding | Multiple cards and faces need a single variable-data plan | Sponsor-specific closure review required |

A wallet or bespoke carton can also be considered for blister or strip coordination. The selected structure is confirmed against packed geometry, orientation, clearance, protocol text, and the opening route rather than an assumed standard size.

What Goes Into the Clinical Packaging Brief?

Send the primary package dimensions, packed weight, complete kit contents, orientation, protocol label text, artwork status, desired structure, quantity, destination, and fill-and-finish responsibilities. State whether the kit needs a patient diary, dosing card, investigator instruction sheet, divider, window, seal, or blank lot and expiry area. For bottles or vials, include closure profiles; for blisters, strips, or ampoules, include the sealed footprint and any protective separation required inside the carton.

Orders start from 50 units on the standard fulfillment path. Production is from 7 business days after digital proof approval, subject to the quoted structure, quantity, artwork, and finish. Pricing remains quote-only because the final size, material, insert, print coverage, and quantity define the specification. A sample kit can be requested when comparing carton, tray, and rigid directions; the sample program has a $44.99 shipping charge credited toward the first order.

How to Brief a Clinical Packaging Manufacturer

1. Confirm the study route: Identify the IMP format, study period, dispensing channel, blinding requirement, and packed contents.
2. Share the protocol copy: Provide approved label text, protocol code, lot and expiry rules, patient identifier fields, storage copy, and patient materials.
3. Choose the structure: Compare folding carton, wallet, rigid box, fitted tray, and compartment options against the packed arrangement.
4. Review the proof: Check fit, blinding, variable-field placement, patient-material order, artwork version, quantity, and quote details before approval.

Review the Proof Before Production

The proof should show the assembled carton or box, primary package, insert relationship, approved protocol copy, blank variable fields, opening direction, and any requested tamper-evident feature. Check that no active ingredient branding appears where blinding is required, that the patient diary or dosing card is in the intended position, and that the clinical packager’s variable-print responsibility is clear. If the protocol, quantity, or label text changes, request a revised structure review instead of assuming the first dieline still applies.

The result is a clinical trial supply packaging brief that connects the investigational product, insert, protocol labelling, patient materials, and dispensing route. It gives the packaging team enough information to quote a folding carton, wallet, rigid box, or compartmented kit while keeping filling, release, and regulatory approval with the responsible clinical partner.